Vaccinations Related Content

Jonathan Jackson, BlackBerry, looks at how vaccine passports and digital vaccine certificates could work - while facing off with cyber-criminals across the world.

Using artificial intelligence (AI), researchers analysed debates based on tweets - revealing that opinions on vaccinations are widely divided.

Médecins Sans Frontières (MSF) found that over 100 manufacturers in Asia, Africa and Latin America are capable of making mRNA COVID vaccines - but pharmaceutical companies won't waive intellectual property rights.

Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.

Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.

December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.

Antibody-like proteins from the immune systems of sharks could help to prepare for future coronaviruses, according to new research.

Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.

According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.

COVID infection previously created 85% protection against Delta - now, scientists say that this protection falls to 19% against Omicron.

Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.

The government is aiming to vaccinate those who are homeless and sleeping rough with the Protect and Vaccinate scheme, relocating people on the street to safe accommodation over winter.

Health charities have come into collaboration with the government and the NHS to promote and advance vaccine update, as UK hits its next milestone in the vaccine rollout.

The NHS COVID Pass can now be used to show proof of a booster or third dose for outbound international travel, records to be shown on NHS App and NHS.UK.

Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

An analysis conducted by US researchers shows 30% of healthcare personnel in more than 2,000 U.S hospitals remain unvaccinated against COVID-19.

A survey shows parents of kids with cancer have similar hesitancy rates as the wider population to vaccinate their children against COVID-19.

A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.

Research by Augusta University, published in Vaccines, found that housing insecurity is connected to vaccine hesitancy in Black communities - especially when it comes to the younger population.